A quick overview of what's new (and what to expect) in migraine prevention. ©IrinaBraga/ Shutterstock
Odor Identification: Marker for Early Alzheimer Disease?
OI may serve for research purposes as a simple and inexpensive indicator of evolving AD pathology. Details here.
Parkinson Disease: Functional Assessment, Gene Disruptions, and More
New Parkinson disease studies offer insights into topics such as LRRK2 G2019S transgene activity, preclinical drug development, and neuroprotection in Parkinson disease.
Migraine Risk Influenced by Extremes of Weight
Too many—or too few—pounds—could be a factor in migraine pathogenesis. Details here.
Smartphone Headache Diaries: Privacy Pros and Cons
Just how private is that information your patient records in a mobile headache diary?
FDA Drug and Biologic Approvals for Neurology: 2017 Midyear Review
Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.
Telemedicine in Your Neurology Practice?
If you are thinking of adding telemedicine to your practice, here are the benefits—and things to consider.
Noninvasive Biomarkers for Epilepsy: A New Way Forward
Thanks to technology, it may be possible to diagnose epilepsy in patients earlier and via noninvasive means.
Vertebral Artery Stenosis: Medical or Surgical Tx?
A meta-analysis compared medical therapy with medical therapy plus angioplasty for the treatment of symptomatic vertebral artery stenosis.
Acoustic Stimulation, Sleep, and Memory
Patients underwent one night of a sham stimulation followed by pink noise stimulation delivered during slow wave activity.
Cannabis, Stroke, and Heart Failure
An abstract presented at ACC 2017 explored the cardiovascular effects of cannabis use.
Chronic Traumatic Encephalopathy: Potential Biomarker
Blood protein analysis of plasma total tau has diagnostic use in Alzheimer disease. Could the same hold true for CTE?
By clicking Accept, you agree to become a member of the UBM Medica Community.